Skip to main content
Clinical Trials/NCT06108791
NCT06108791CompletedNot Applicable

High vs Low Inspired Intraoperative Oxygen Concentration on the Incidence of Surgical Site Infection in Hepatobiliary Surgeries

Assiut University1 site in 1 country146 target enrollmentStarted: April 3, 2025Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
146
Locations
1
Primary Endpoint
Incidence of SSI

Study Overview

Brief Summary

Surgical site infections (SSI) are the most common healthcare-associated infections and sources of morbidity and over-mortality. Factors that have been proven to reduce SSI include antimicrobial prophylaxis, maintenance of perioperative normothermia, avoidance of hyperglycemia, proper surgical techniques, and adequate pain relief postoperatively

Detailed Description

In 2016, a systematic review and meta-analysis assessing the effects of systematic high FiO2 (80%) compared with standard FiO2 (30%) concluded that high FiO2 was associated with a reduction of SSI in patients undergoing surgery under general anesthesia. Consequently, the WHO recommended that "adult patients undergoing general anesthesia should receive an 80% FiO2 intra-operatively to reduce the risk of SSI".These recommendations have sparked a large debate on the benefits and harms of hyperoxemia. From the theoretical point-of-view, several pro (prevention of hypoxemia, SSI, and postoperative nausea and vomiting) and con (respiratory adverse events, increased production of harmful "reactive oxygen species") arguments have been raised by believers and detractors of high FiO2. Accordingly, and despite these recommendations, anesthetists still used a wide range of intraoperative FiO2 in daily practice and frequently changed FiO2 settings during surgery unrelated to patients' PaO2 or SpO2.

The PROXI study, the largest multicenter randomized controlled trial specifically designed to assess the role of high vs. low intraoperative FiO2 on SSI, did not report any reduction of the incidence of SSI with the administration of 80% FiO2 during colorectal surgery. Similarly, the recent multicenter randomized iPROVE-O2 trial that included 740 patients undergoing major abdominal surgery, ventilated intraoperatively with an evidence-based protective strategy, reported a similar SSI rate between the 30% and 80% FiO2 groups.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Prevention
Masking
Double (Participant, Outcomes Assessor)

Eligibility Criteria

Ages
18 Years to 80 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • - BMI of <35 kg/m2
  • scheduled for elective abdominal laparotomy/ laparoscopy under general anesthesia with an expected surgical time longer than 2 h.
  • ASA I and II

Exclusion Criteria

  • - Patients undergoing minor procedures, where the expected duration of surgery will be less than 1 hour.
  • emergency surgeries for bowel obstruction.
  • abdominal surgery for vascular or plastic indications.
  • patients with a recent history of fever,
  • patients with uncontrolled diabetes mellitus,
  • patient with known immunological dysfunction (on steroids, decompensated liver disease, HIV, etc.).

Arms & Interventions

HIGH FIO2

Active Comparator

will include 50 patients: each one will receive intraoperatively a high concentration of oxygen (80% oxygen + 20% air), following extubation, high-concentration oxygen supplementation will be maintained and given through non-rebreathing face mask with a reservoir at 10 L/min for 2 h.

Intervention: FIO2=0.8 (Drug)

LOW FIO2

Placebo Comparator

will include 50 patients: each one will receive intraoperatively standard concentration oxygen (33% oxygen + 66% air) followed by oxygen supplementation through the standard Venturi face mask of 30%

Intervention: FIO2=0.33 (Drug)

Outcomes

Primary Outcomes

Incidence of SSI

Time Frame: 30 DAYS

\- the incidence of SSI postoperatively according to the Centers for Disease Control (CDC) criteria up to 30 days

Secondary Outcomes

  • Pulmonary complications(14 days)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Shimaa Abbas Hassan

lecturer

Assiut University

Study Sites (1)

Loading locations...

Similar Trials

Intraoperative Oxygen Concentration on... | Clinical Trial